We welcome inquiries from investors, strategic partners, and clinical collaborators interested in the future of vascular access.
For investor relations, partnership opportunities, or general inquiries, reach out to our team directly.
ensovascular@gmail.comSeed and early-stage investors with interest in medtech, digital health, or specialty pharma.
Medical device and pharmaceutical companies exploring vascular access innovation or topical drug delivery platforms.
Interventional cardiologists and vascular access specialists interested in clinical trial participation or advisory roles.